today announced that the company will present preclinical data from the PBGENE-DMD program for the treatment of Duchenne muscular dystrophy (DMD) during an oral presentation at the 2025 Muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback